SCHEMBL5006583

SCHEMBL5006583

COC(=O)c1ccc(N)c(C(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.48
MAPT P10636 7/20 0.48
ALDH1A1 P00352 6/20 0.48
HPGD P15428 6/20 0.48
GAA P10253 3/20 0.48
HSD17B10 Q99714 2/20 0.48
GLA P06280 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
ATM Q13315 1/20 0.48
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PKM P14618 1/20 0.42
USP2 O75604 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14008534 0.80 ALDH1A1 (0.40) KDM4EMAPTALDH1A1HPGDGAA
SCHEMBL5004220 0.79 VCAM1 (0.51) MAPTALDH1A1HPGDGAANPSR1
SCHEMBL3409060 0.78 KEAP1 (0.40) ALDH1A1HDAC1LMNA
SCHEMBL19900116 0.77 MAPT (0.57) KDM4EMAPTALDH1A1HPGDGAA
SCHEMBL4119820 0.76 MAPT (0.56) KDM4EMAPTALDH1A1HPGDGAA
SCHEMBL15441561 0.76 CA1 (0.47) KDM4EMAPTALDH1A1GAANPC1
SCHEMBL4996633 0.76 CFTR (0.39) KDM4EMAPTALDH1A1HPGDGAA
SCHEMBL17055697 0.75 MAPT (0.54) KDM4EMAPTALDH1A1HPGDGAA
SCHEMBL3414451 0.74 LMNA (0.43) ALDH1A1HSD17B10LMNA
SCHEMBL1495845 0.74 GRM1 (0.48) KDM4EMAPTALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
WO-2008084300-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER PRODUCTS INC. (US) 2008-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE SPTLC1, SPTLC2, CPT1A KDM4E 3508/4885MAPT 1776/4885ALDH1A1 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.